Market capitalization | $110.56b |
Enterprise Value | $131.12b |
P/E (TTM) P/E ratio | 26.28 |
EV/FCF (TTM) EV/FCF | 23.84 |
EV/Sales (TTM) EV/Sales | 3.97 |
P/S ratio (TTM) P/S ratio | 3.35 |
P/B ratio (TTM) P/B ratio | 2.28 |
Dividend yield | 3.20% |
Last dividend (FY24) | $2.76 |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
35 Analysts have issued a Medtronic forecast:
35 Analysts have issued a Medtronic forecast:
Oct '24 |
+/-
%
|
||
Revenue | 32,996 32,996 |
3%
3%
|
|
Gross Profit | 22,236 22,236 |
16%
16%
|
|
EBITDA | 8,617 8,617 |
1%
1%
|
EBIT (Operating Income) EBIT | 5,977 5,977 |
3%
3%
|
Net Profit | 4,287 4,287 |
5%
5%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Head office | United States |
CEO | Geoffrey Martha |
Employees | 95,000 |
Founded | 2014 |
Website | www.medtronic.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.